Cover Image
Market Research Report

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia

Published by GlobalData Product code 907765
Published Content info 140 Pages
Delivery time: 1-2 business days
Price
Back to Top
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia
Published: August 2, 2019 Content info: 140 Pages
Description

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Saudi Arabia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Saudi Arabia. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the Saudi Arabia, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (GlaxoSmithKline, Novartis, Pfizer, Tabuk Pharmaceuticals and Saudi Arabian Pharmaceutical Industries & Medical Appliances Corp) and profiles and SWOT analyses of the major players in the medical device market (Cardinal Health, Fujitsu, AstraZeneca, GE Healthcare, and Kimberly-Clark Corporation)
  • Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Saudi Arabia
  • Porter's five forces analysis for pharmaceutical and medical devices market of Saudi Arabia
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs
  • Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities and challenges to growth in the Saudi Arabian healthcare market.

Reasons to buy

This report will enhance your decision-making capability by allowing you to -

  • Develop business strategies by understanding the trends shaping and driving the Saudi Arabian healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in the Saudi Arabian healthcare market.
Table of Contents
Product Code: GDHC0064CHR

Table of Contents

  • Executive Summary
  • Overview of Pharmaceutical Market
  • Overview of Medical Device Market
  • Deals Analysis
  • Porter's Five Forces Model
  • Market Access
  • Country Healthcare Landscape
  • Opportunities and Challenges
  • Appendix

List of Tables

  • Table 1: Opportunities in Pharmaceutical and Biotech Clusters, Saudi Arabia, 2019
  • Table 2: Pharmaceutical Market, Saudi Arabia, Sales of Patented Drug Products by Major Therapeutic Class (%), 2010-2015
  • Table 3: Medical Device Market, Saudi

List of Figures

  • Figure 1: Pharmaceutical Market, Saudi Arabia, Revenue ($B), 2013-2018
  • Figure 2: Medical Device Market, Saudi Arabia, Revenue ($B), 2015-2020
  • Figure 3: Number of Deals (2018-2019)
  • Figure 4: 2018-19 Deal Overview By Region
  • Figure 5: Country
Back to Top